Canopy Growth (TSX:WEED): 1 of the Best Marijuana Stocks to Buy

Canopy Growth Corp’s (TSX:WEED)(NYSE:CGC) growing operations and its deal activity make it one of the best marijuana stock to buy.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

The marijuana space is becoming big and confusing. There are several companies in Canada and the U.S. trying to win investor confidence in this nascent industry by putting out ambitious growth plans. 

But if you’re a long-term investor and are thinking of getting some exposure to this new growth area, then I highly recommend sticking with the big players, which have durable competitive advantages and the best chances to meet your expectations.

With theme in mind, I believe Canada’s largest pot producer, Canopy Growth (TSX:WEED)(NYSE:CGC), is your best bet. Here is why.

Growing operations

Canopy is one of the few weed companies that very early amassed the size and the market share in this new industry. What positions Canopy to deliver superior returns over the long run is its market size, capacity to ramp up production, and its vast international reach.

Canopy currently operates weed-growing facilities with over 2.4 million square feet of space. The producer has been expanding its operations quickly, which will deliver the potential to manage more than five million square feet of production space by next year.

With this market power, the producer is also consolidating its position in the market where some companies are looking to exit. In a development reported by Bloomberg News, Canopy was nearing a deal to buy Acreage Holdings in what would be the first major cross-border cannabis merger.

The deal, which could be announced as soon as this week, would be a major milestone for Canopy, as it will be able to bring one of the largest U.S.-based pot firms under its umbrella. Acreage has cultivation, processing, and dispensing licences or agreements with holders in 19 states in the U.S. It also manages a chain of retail stores called The Botanist.

As part of its plan to build an extraction and manufacturing facility in the U.S., a much bigger market for both medical and recreational marijuana, Canopy acquired a hemp licence in New York State early this year.

Initiatives like this and the company’s partnership with the Constellation Brands make Canopy a formidable player in the marijuana space and more appealing to investors looking for exposure to the U.S. cannabis market.

Constellation, the maker of popular Modelo and Corona beer, raised its stake in Canopy to 37% last August after investing about US$4 billion with the option of taking majority control of the company in the future.

Bottom line

Trading around $61 a share at the time of writing, Canopy stock has already surged more than 60% this year, benefiting from its leading position in the industry and due to its growing sales, which, according its CEO, will hit $1 billion mark in 2020.

For many conservative investors, the stock may look too pricey after such a massive rally, but that perception may not be true for a company that’s in its initial stage of growth. Canopy’s smart deal activity and its position in the market suggest to me that its stock is well on track to hit an $80 mark this year.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Haris Anwar has no positions in the stocks mentioned in this report.

More on Cannabis Stocks

Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.
Cannabis Stocks

Canopy Growth: Is There Budding Potential in the Cannabis Market?

Canopy Growth stock hit 52-week lows recently on news of needing to re-file on its BIoSteel business, so what now?

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

What’s Happening With Cannabis Stocks in May 2023?

Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is…

Read more »

Cannabis smoke
Cannabis Stocks

Are Cannabis Stocks a Good Buy in May 2023?

If you're going to buy cannabis stocks, these are pretty much the only two I would consider. Even so, you…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Aurora Cannabis: Time to Light Up Your Portfolio?

Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth…

Read more »

Target. Stand out from the crowd
Tech Stocks

These Undervalued TSX Stocks Are a Bargain in May 2023

If you're willing to bet on a rebound, these are the three TSX stocks I would consider first as they…

Read more »

A cannabis plant grows.
Cannabis Stocks

Tilray Stock Is Scraping 52-Week Lows: Will it Bottom Out Soon?

Tilray (TSX:TLRY) stock remains down 53% in the last year, but when will this company hit the bottom and start…

Read more »

Medicinal research is conducted on cannabis.
Metals and Mining Stocks

2 Canadian Stocks That Are Simply Too Cheap to Avoid

These two Canadian stocks have sunk lower and lower, which is why now could be the right time for long-term…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

1 Marijuana Stock I’d Buy Over Aurora Cannabis

Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio.

Read more »